<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-045003</identifier>
<setSpec>1130-1406</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Systemic antifungals. Pharmacodynamia and pharmacokinetics</dc:title>
<dc:description xml:lang="en">Invasive fungal infections are important causes of morbidity and mortality in criticallyill non neutropenic patients. For many years, amphotericin B and flucytosinehave been the only available antifungal agents for invasive fungal infections.Fortunately, the antifungal armamentarium has increased during the past twodecades with the addition of several new agents. In addition to itraconazole andfluconazole, lipid formulations of amphotericin B, voriconazole, and caspofunginhave been recently licensed. These various antifungal agents differ in their pharmacokineticand pharmacodynamic profile</dc:description>
<dc:creator>Montejo, Juan Carlos</dc:creator>
<dc:creator>Catalán, Mercedes</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Las infecciones fúngicas invasoras producen una elevada morbimortalidad enlos pacientes críticos no neutropénicos. Durante muchos años, la anfotericina By flucitosina han sido los únicos antifúngicos disponibles para el tratamiento deeste tipo de infecciones. Afortunadamente, el arsenal terapéutico de antifúngicosse ha ampliado en las dos últimas décadas con la aparición de nuevos antimicóticos:itraconazol, fluconazol, fórmulaciones lipídicas de anfotericina B, voriconazoly caspofungina, ya comercializados. Estos antifúngicos difieren en suespectro farmacocinético y farmacodinámico</dc:description>
<dc:source>Rev Iberoam Micol;23(1): 39-49, ene. 2006. ilus, tab</dc:source>
<dc:identifier>ibc-045003</dc:identifier>
<dc:title xml:lang="es">Antifúngicos sistémicos. Farmacodinamia y farmacocinética</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d3439^s22045</dc:subject>
<dc:subject>^d27953^s22079</dc:subject>
<dc:subject>^d2209^s22057</dc:subject>
<dc:subject>^d7274^s22079</dc:subject>
<dc:subject>^d943^s22000</dc:subject>
<dc:subject>^d5570^s22079</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:type>article</dc:type>
<dc:date>200601</dc:date>
</metadata>
</record>
</ibecs-document>
